[Hematologic malignancies /pediatric malignancies-current status of molecular target therapy for hematologic cancer].
Department of Oncology and Hematology, Jikei University School of Medicine, Komae-shi, Tokyo, Japan.
Noriko
N
Usui
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D015195:Drug Design; D019337:Hematologic Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D015398:Signal Transduction / Q000187:drug effects
D000970:Antineoplastic Agents